Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter N Monk

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
The Journal of Biological Chemistry|January 22, 2005
Comparative agonist/antagonist responses in mutant human C5a receptors define the ligand binding siteAdrian Higginbottom, Stuart A Cain, Trent M Woodruff, et al.
International Journal of Molecular Sciences|October 4, 2018
Inhibition of Tetraspanin Functions Impairs Human Papillomavirus and Cytomegalovirus InfectionsLaura A Fast, Snježana Mikuličić, Anna Fritzen, et al.
Journal of Medicinal Chemistry|April 17, 2012
De novo peptide design with C3a receptor agonist and antagonist activities: theoretical predictions and experimental validationMeghan L Bellows-Peterson, Ho Ki Fung, Christodoulos A Floudas, et al.
European Journal of Pharmacology|December 3, 2014
Derivation of ligands for the complement C3a receptor from the C-terminus of C5aReena Halai, Meghan L Bellows-Peterson, Will Branchett, et al.
The Ocular Surface|July 5, 2023
Tetraspanin CD9-derived peptides inhibit Pseudomonas aeruginosa corneal infection and aid in wound healing of corneal epithelial cellsPraveen Kumar Jadi, Alpana Dave, Rahaf Issa, et al.
Immunology and Cell Biology|April 26, 2016
Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signallingDaniel E Croker, Peter N Monk, Reena Halai, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 4, 2006
Therapeutic activity of C5a receptor antagonists in a rat model of neurodegenerationTrent M Woodruff, James W Crane, Lavinia M Proctor, et al.
Microbial Pathogenesis|March 10, 2023
Phage-based therapy against biofilm producers in gram-negative ESKAPE pathogensNaveen Kumar Devanga Ragupathi, Dhiviya Prabaa Muthuirulandi Sethuvel, Mohanraj Gopikrishnan, et al.
Npj Antimicrobials and Resistance|January 22, 2025
Phage therapy could be key to conquering persistent bacterial lung infections in childrenAye Mya Sithu Shein, Parichart Hongsing, Aisha Khatib, et al.
Critical Reviews in Microbiology|July 1, 2024
Current and novel therapies for management of <i>Acinetobacter baumannii</i>-associated pneumoniaAye Mya Sithu Shein, Parichart Hongsing, O'Rorke Kevin Smith, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
The Journal of Biological Chemistry|January 22, 2005
Comparative agonist/antagonist responses in mutant human C5a receptors define the ligand binding siteAdrian Higginbottom, Stuart A Cain, Trent M Woodruff, et al.
International Journal of Molecular Sciences|October 4, 2018
Inhibition of Tetraspanin Functions Impairs Human Papillomavirus and Cytomegalovirus InfectionsLaura A Fast, Snježana Mikuličić, Anna Fritzen, et al.
Journal of Medicinal Chemistry|April 17, 2012
De novo peptide design with C3a receptor agonist and antagonist activities: theoretical predictions and experimental validationMeghan L Bellows-Peterson, Ho Ki Fung, Christodoulos A Floudas, et al.
European Journal of Pharmacology|December 3, 2014
Derivation of ligands for the complement C3a receptor from the C-terminus of C5aReena Halai, Meghan L Bellows-Peterson, Will Branchett, et al.
The Ocular Surface|July 5, 2023
Tetraspanin CD9-derived peptides inhibit Pseudomonas aeruginosa corneal infection and aid in wound healing of corneal epithelial cellsPraveen Kumar Jadi, Alpana Dave, Rahaf Issa, et al.
Immunology and Cell Biology|April 26, 2016
Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signallingDaniel E Croker, Peter N Monk, Reena Halai, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 4, 2006
Therapeutic activity of C5a receptor antagonists in a rat model of neurodegenerationTrent M Woodruff, James W Crane, Lavinia M Proctor, et al.
Microbial Pathogenesis|March 10, 2023
Phage-based therapy against biofilm producers in gram-negative ESKAPE pathogensNaveen Kumar Devanga Ragupathi, Dhiviya Prabaa Muthuirulandi Sethuvel, Mohanraj Gopikrishnan, et al.
Npj Antimicrobials and Resistance|January 22, 2025
Phage therapy could be key to conquering persistent bacterial lung infections in childrenAye Mya Sithu Shein, Parichart Hongsing, Aisha Khatib, et al.
Critical Reviews in Microbiology|July 1, 2024
Current and novel therapies for management of <i>Acinetobacter baumannii</i>-associated pneumoniaAye Mya Sithu Shein, Parichart Hongsing, O'Rorke Kevin Smith, et al.
Pageof 8